UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Suppression of tumor metastasis by a RECK-activating small molecule

Scientific reports, 2022-02, Vol.12 (1), p.2319-2319, Article 2319

2022

Volltextzugriff (PDF)

High‐throughput screening in colorectal cancer tissue‐originated spheroids

Cancer science, 2019-01, Vol.110 (1), p.345-355

2019

Volltextzugriff (PDF)

Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis

Scientific reports, 2019-06, Vol.9 (1), p.8666-11, Article 8666

2019

Volltextzugriff (PDF)

Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor

JNCI : Journal of the National Cancer Institute, 2006-04, Vol.98 (8), p.545-556

2006

Volltextzugriff (PDF)

Antitumor effects of tyropeptin‐boronic acid derivatives: New proteasome inhibitors

Cancer science, 2014-12, Vol.105 (12), p.1609-1615

2014

Volltextzugriff (PDF)

Development and Characterization of a Model of Liver Metastasis Using Human Colon Cancer HCT-116 Cells

Biological and Pharmaceutical Bulletin, 2007/09/01, Vol.30(9), pp.1779-1783

2007

Volltextzugriff (PDF)

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

Oncotarget, 2018-10, Vol.9 (80), p.35141-35161

2018

Volltextzugriff (PDF)

Discovery of Phosphatidylinositol 3-Kinase Inhibitory Compounds from the Screening Committee of Anticancer Drugs (SCADS) Library

Biological and Pharmaceutical Bulletin, 2010/09/01, Vol.33(9), pp.1600-1604

2010

Volltextzugriff (PDF)

Evaluation of Action Mechanisms of Toxic Chemicals Using JFCR39, a Panel of Human Cancer Cell Lines

Molecular pharmacology, 2007-11, Vol.72 (5), p.1171-1180

2007

Volltextzugriff (PDF)

Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays

Molecular cancer therapeutics, 2005-03, Vol.4 (3), p.399-412

2005

Volltextzugriff (PDF)

Identification of Candidate Genes Determining Chemosensitivity to Anti-cancer Drugs of Gastric Cancer Cell Lines

Biological and Pharmaceutical Bulletin, 2009/11/01, Vol.32(11), pp.1936-1939

2009

Volltextzugriff (PDF)

Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents

Biochemical pharmacology, 2008-03, Vol.75 (5), p.1014-1026

2008

Volltextzugriff (PDF)

Abstract 384: Identification of a lung adenocarcinoma cell line addicted to ERBB4, an actionable target for cancer therapy

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.384-384

2019

Volltextzugriff (PDF)

Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines

Cancer science, 2003-12, Vol.94 (12), p.1074-1082

2003

Volltextzugriff (PDF)

In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA

Investigational new drugs, 2014-12, Vol.32 (6), p.1134-1143

2014

Volltextzugriff (PDF)

Abstract 3909: Potential antitumor effect of a pan-PI3K inhibitor ZSTK474 on human sarcoma cell lines

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3909-3909

2019

Volltextzugriff (PDF)

Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations

Cancer research (Chicago, Ill.), 2010-06, Vol.70 (12), p.4982-4994

2010

Volltextzugriff (PDF)

AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy

The Journal of biological chemistry, 2012-02, Vol.287 (6), p.3885-3897

2012

Volltextzugriff (PDF)

Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth

ACS chemical biology, 2021-11, Vol.16 (11), p.2570-2580

2021

Volltextzugriff (PDF)

Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling

Oncology research, 2023-01, Vol.31 (6), p.833-844

2023

Volltextzugriff (PDF)

An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines

Cancer research (Chicago, Ill.), 2002-02, Vol.62 (4), p.1139-1147

2002

Volltextzugriff (PDF)

Antitumor effects of tyropeptin‐boronic acid derivatives. Gene expression analyses of RPMI8226 cells treated with tyropeptin‐boronic acid derivatives using Agilent human whole genome microarray

Cancer science, 2014-12, Vol.105 (12), p.December cover-December cover

2014

Volltextzugriff (PDF)

Solvent and Temperature Effect on Chiral Conformation of Poly(m-benzamide)s

Macromolecules, 2006-04, Vol.39 (7), p.2432-2434

2006

Volltextzugriff (PDF)

p53-Defective Tumors With a Functional Apoptosome-Mediated Pathway: A New Therapeutic Target

JNCI : Journal of the National Cancer Institute, 2005-05, Vol.97 (10), p.765-777

2005

Volltextzugriff (PDF)

Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel

Cancer research (Chicago, Ill.), 1999-08, Vol.59 (16), p.4042-4049

1999

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(52)
Tagungsberichte
(1)

Sprache

Englisch
(53)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(33)
Humans
(27)
Animals
(16)
Cell Line, Tumor
(15)
Antineoplastic Agents - Pharmacology
(13)
Oncology
(13)
Pharmacology & Pharmacy
(13)
Biological And Medical Sciences
(11)
Medical Sciences
(10)
Female
(9)
Mice
(9)
Pharmacology. Drug Treatments
(8)
Tumors
(8)
Antineoplastic Agents
(7)
Enzyme Inhibitors - Pharmacology
(6)
Pharmacology
(6)
Biochemistry & Molecular Biology
(5)
Chemotherapy
(5)
Drug Screening Assays, Antitumor
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Suppression of tumor metastasis by a RECK-activating small molecule

High‐throughput screening in colorectal cancer tissue‐originated spheroids

Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis

Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor

Antitumor effects of tyropeptin‐boronic acid derivatives: New proteasome inhibitors

Development and Characterization of a Model of Liver Metastasis Using Human Colon Cancer HCT-116 Cells

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

Discovery of Phosphatidylinositol 3-Kinase Inhibitory Compounds from the Screening Committee of Anticancer Drugs (SCADS) Library

Evaluation of Action Mechanisms of Toxic Chemicals Using JFCR39, a Panel of Human Cancer Cell Lines

Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays

Identification of Candidate Genes Determining Chemosensitivity to Anti-cancer Drugs of Gastric Cancer Cell Lines

Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents

Abstract 384: Identification of a lung adenocarcinoma cell line addicted to ERBB4, an actionable target for cancer therapy

Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines

In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA

Abstract 3909: Potential antitumor effect of a pan-PI3K inhibitor ZSTK474 on human sarcoma cell lines

Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations

AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy

Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth

Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling

An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines

Antitumor effects of tyropeptin‐boronic acid derivatives. Gene expression analyses of RPMI8226 cells treated with tyropeptin‐boronic acid derivatives using Agilent human whole genome microarray

Solvent and Temperature Effect on Chiral Conformation of Poly(m-benzamide)s

p53-Defective Tumors With a Functional Apoptosome-Mediated Pathway: A New Therapeutic Target

Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel

Suchergebnisse filtern